New Zealand's government plans to repeal the Therapeutic Products Act and replace it with a better system for safe and timely access to medicines.
New Zealand's government will repeal the Therapeutic Products Act (TPA) to replace it with a better system providing safe and timely access to medicines, medical devices, and health products for New Zealanders. The current Medicines Act is outdated, and the TPA was deemed not the solution, as it would have over-regulated some products and imposed unnecessary costs. The repeal aims to address concerns from industry and consumers, ensuring cost-effective access to the right products and reducing barriers for exporters.
May 08, 2024
5 Articles